Clinical trial
Phase II Trial With Lenalidomide-Dexamethasone Combination in the Treatment of POEMS Syndrome.
NCT01639898 is registered in ClinicalTrials.gov with University Hospital, Limoges as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Trial With Lenalidomide-Dexamethasone Combination in the Treatment of POEMS Syndrome.
- Lead sponsor
- University Hospital, Limoges
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 31, 2012
- Completion date
- July 31, 2018
- Enrollment
- 51 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.